Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Multiple Study of Electroaccpuncture in ARDS

In order to clarify the clinical efficacy of electroacupuncture on inhibiting systemic inflammatory response, improving respiratory mechanics parameters and prognosis in patients with sepsis-related ARDS.

Participants needed: 264
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Nanjing University of Traditional Chinese MedicineUpdated: Apr 23, 2024Locations: 1
Eligibility criteria

Meet the diagnostic criteria of the Surviving Sepsis Campaign: Updated Internati... [+5]

Participated in other clinical trials [+8]

Status: Not yet recruiting

Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.

This study intends to further evaluate the efficacy of acupuncture by comparing the intervention effects of different acupuncture treatment regimens on hot flashes in breast cancer ; and to explore the central effect regulation mechanism of acupuncture intervention on hot flashes based on integrated PET/MRI technology.

Participants needed: 90
Trial details
Age: 30-75Biological sex: FemaleType: InterventionalSponsor: Nanjing University of Traditional Chinese MedicineUpdated: Nov 16, 2022Locations: 1
Eligibility criteria

Aged 30-75 years old; [+5]

Tumor metastases, undergoing chemoradiotherapy or planning surgery; [+5]

Status: Not yet recruiting

Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.

This study intends to further evaluate the efficacy of acupuncture by comparing the intervention effects of different acupuncture treatment regimens on hot flashes in breast cancer ; and to explore the central effect regulation mechanism of acupuncture intervention on hot flashes based on functional magnetic resonance imaging technology.

Participants needed: 90
Trial details
Age: 18-75Biological sex: FemaleType: InterventionalSponsor: Nanjing University of Traditional Chinese MedicineUpdated: Jul 20, 2022Locations: 1
Eligibility criteria

Aged 18-75 years old; [+7]

Tumor metastases, undergoing chemoradiotherapy or planning surgery; [+8]